Ristigo (Rozanolixizumab)30:10-31:26
This is Lauren Vogelbaum from BrainStuff, and this episode is brought to you by Ristigo. Struggling with symptoms from generalized myasthenia gravis, or GMG? Discover what's in reach with Ristigo, or Rosanolixizumab noli, the first FDA-approved targeted treatment for adults with either anti-ACHR or anti-Musk antibody-positive GMG. Ristigo may cause serious side effects, including infection, aseptic meningitis, and or hypersensitivity reactions. Tell your doctor right away if you have signs or symptoms of an infection, meningitis, or any other undesirable reactions. Administration of live or live attenuated vaccines is not recommended during treatment. The most common side effects include headache, infections, diarrhea, fever, hypersensitivity reactions, and nausea. Ask your doctor about Ristigo. For more information, call 1-844-599-2273 or visit ry273.ggo.com.
mid-rollno codeDetected Aug 12
Est. value ~$240 · range $36–$1.7K